Cargando…

Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial

IMPORTANCE: Health care workers (HCWs) caring for patients with coronavirus disease 2019 (COVID-19) are at risk of exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, to our knowledge, there is no effective pharmacologic prophylaxis for individuals at risk. OBJECTIVE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abella, Benjamin S., Jolkovsky, Eliana L., Biney, Barbara T., Uspal, Julie E., Hyman, Matthew C., Frank, Ian, Hensley, Scott E., Gill, Saar, Vogl, Dan T., Maillard, Ivan, Babushok, Daria V., Huang, Alexander C., Nasta, Sunita D., Walsh, Jennifer C., Wiletyo, E. Paul, Gimotty, Phyllis A., Milone, Michael C., Amaravadi, Ravi K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527945/ https://www.ncbi.nlm.nih.gov/pubmed/33001138 http://dx.doi.org/10.1001/jamainternmed.2020.6319

Ejemplares similares

Impact of acute intoxication on quantitative pupillometry assessment in the emergency department
por: Jolkovsky, Eliana L., et al.
Publicado: (2022)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis
por: Faruqui, Atiya R., et al.
Publicado: (2021)

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
por: Boulware, David R., et al.
Publicado: (2020)

Risks of hydroxychloroquine use for COVID-19 prophylaxis
por: Sachdeva, Muskaan, et al.
Publicado: (2020)

Hydroxychloroquine prophylaxis for COVID-19 contacts in India
por: Rathi, Sahaj, et al.
Publicado: (2020)

Hydroxychloroquine as Prophylaxis for COVID-19: A Review
por: Monti, Manuela, et al.
Publicado: (2020)

BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma
por: Mehnert, Janice M., et al.
Publicado: (2022)

COVID-19: Hydroxychloroquine prophylaxis is just a prophylaxis! Be careful and perceive it right
por: Garg, Rakesh, et al.
Publicado: (2022)

Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection
por: Carafoli, Ernesto
Publicado: (2021)

Response to: “Risks of hydroxychloroquine use for COVID-19 prophylaxis”
por: Grant-Kels, Jane M.
Publicado: (2020)

Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health-care workers
por: Simova, I., et al.
Publicado: (2020)

Potentials of Interferons and Hydroxychloroquine for the Prophylaxis and Early Treatment of COVID-19
por: Yang, Alexander, et al.
Publicado: (2020)

Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
por: Pareek, Anil, et al.
Publicado: (2020)

Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19: What Is Known?
por: Shankar, Pathiyil Ravi, et al.
Publicado: (2021)

Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19
por: Kulkarni, Chanda, et al.
Publicado: (2021)

Hydroxychloroquine Pre-Exposure Prophylaxis for COVID-19 in Healthcare Workers from India: A Meta-Analysis
por: Stricker, Raphael B., et al.
Publicado: (2021)

Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials
por: Hong, Hwanhee, et al.
Publicado: (2023)

Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
por: Rajasingham, Radha, et al.
Publicado: (2020)

Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19
por: Yang, Alexander, et al.
Publicado: (2020)

Interpreting the impact of hydroxychloroquine prophylaxis on SARS-CoV-2 infection
por: Yadav, Reetika Malik, et al.
Publicado: (2021)

Side effects of hydroxychloroquine prophylaxis against COVID-19 in healthcare workers
por: Dixit, Prashant Kumar, et al.
Publicado: (2021)

Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer
por: Karasic, Thomas B, et al.
Publicado: (2022)

Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
por: Galvis, Virgilio, et al.
Publicado: (2020)

Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
por: Galvis, Virgilio, et al.
Publicado: (2020)

Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead
por: Singh, Harmanjit, et al.
Publicado: (2021)

Hydroxychloroquine as antiviral prophylaxis for exposed caregivers to Covid-19: An urgent appraisal is needed()
por: Tahiri Joutei Hassani, Rachid, et al.
Publicado: (2020)

Hydroxychloroquine in the prophylaxis of COVID 19: A survey of safety on the healthcare workers in India
por: Mukhopadhyay, Sandip, et al.
Publicado: (2021)

Hydroxychloroquine for prophylaxis of COVID-19 in health workers: A randomized clinical trial
por: Rojas-Serrano, Jorge, et al.
Publicado: (2022)

Hydroxychloroquine prophylaxis for SARS-CoV-2 infection among healthcare workers
por: Karim, Habib M.R., et al.
Publicado: (2020)

Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ)
por: Naggie, Susanna, et al.
Publicado: (2023)

Severe aplastic anaemia after serial vaccinations for SARS‐CoV‐2, pneumococcus and seasonal influenza
por: Wang, Xiao, et al.
Publicado: (2022)

SP48. A Novel Flap Technique for Repairing Mohs Micrographic Surgery Nasal Defects
por: McCleary, Sean Patrick, et al.
Publicado: (2023)

Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach
por: Tilangi, Praveen, et al.
Publicado: (2020)

Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial
por: Rajasingham, Radha, et al.
Publicado: (2020)

Clinical Issues in the Prophylaxis, Diagnosis, and Treatment of Anthrax
por: Bell, David M., et al.
Publicado: (2002)

SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis
por: Dousa, Khalid M., et al.
Publicado: (2020)

Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
por: Kaur, Hardeep, et al.
Publicado: (2021)

Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models
por: Rosenke, Kyle, et al.
Publicado: (2020)

The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article
por: Shah, Shagun B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b69v5c33cuutjuor452jrn6vb9